CD47 and neoplasm: This neoplasm is characterized by overexpression of CD47, and it has been found that the use of B6H12.2, or other monoclonal antibodies, either promotes CD47 decrease or the stimulation of phagocytosis by macrophages, highlighting the importance of this receptor in the maintenance of this neoplasm [127].